Applied Clinical Trials
A comprehensive listing of U.S. departments and offices that includes the telephone numbers of directors, commissioners, and advisors.
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Director
Jerry Menikoff (240) 453-6900
NIH Institutes, Center, and Divisions
Deputy Director and Director, Office of International Activities
Melody Lin (240) 453-8126
Associate Director, Regulatory Affairs
Michael Carome (240) 453-8237
Director, Division of Compliance Oversight
Kristina Borror (240) 453-8132
Director, Division of Education and Development
Elyse Summers* (240) 453-8236
Director,Division of Policy and Assurances
Irene Stith-Coleman (240) 453-8138
FOOD AND DRUG ADMINISTRATION
Commissioner
Andrew von Eschenbach (301) 827-3310
Principal Deputy Commissioner and Chief Scientist
Frank Torti (301) 827-3310
Chief of Staff
Susan Winckler (301) 827-0087
Deputy Commissioner for Operations and Chief Operating Officer
John Dyer (301) 827-1166
Deputy Commissioner for Policy, Planning, and Preparedness
Randall Lutter (301) 827-3370
Deputy Commissioner for International and Special Programs
Murray Lumpkin (301) 827-5709
Chief Counsel
Gerald Masoudi (301) 827-1137
Assistant Commissioner for External Relations
Larry Bachorik* (301) 827-1352
Assistant Commissioner for Policy and Planning
Jeffrey Shuren (301) 827-3360
Assistant Commissioner for Planning
Malcolm Bertoni (301) 827-5292
Assistant Commissioner for Counterterrorism and Emerging Threats
Boris Lushniak (301) 827-4067
DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION
Assistant Commisioner for Integrity and Accountability
William McConagha (301) 827-4427
Associate Commissioner for International Programs
Melinda Plaisier (301) 827-4480
Director, Office of Pediatric Therapeutics
Dianne Murphy (301) 827-1996
Director, Office of Combination Products
Thinh Nguyen (301) 427-1934
Associate Commissioner for Management
Kathleen Heuer (301) 255-6762
Associate Commissioner for Critical Path Programs
Rachel Behrman (301) 827-1512
Director, National Center for Toxicological Research
William Slikker (870) 543-7203
Associate Commissioner for Science and Health Coordination
Norris Alderson (301) 827-3340
Assistant Commissioner for Women's Health
Kathleen Uhl (301) 827-0350
Director, Office of Orphan Products Development
Timothy Cote (301) 827-3666
GoodClinicalPracticeProgram
Director
Joanne Less (301) 827-3340
Special Assistant to the Director
Patricia Beers Block (301) 827-3340
Senior Bioethicist
Sara Goldkind (301) 827-3340
Expert Consumer Safety Officer
Carolyn Hommel (301) 827-3340
Senior Advisor for Clinical Science
David Lepay (301) 827-3340
Policy Analyst
Marsha Melvin (301) 827-3340
Senior Health Policy Analyst
Kathleen Pfaender (301) 827-3340
Biophysicist
Jean Toth-Allen (301) 827-3340
Associate Commissioner for Regulatory Affairs
Michael Chappell (301) 827-3107
Associate Deputy Commissioner for Compliance Policy
Steven Solomon (301) 827-3101
Director
Daniel Schultz (240) 276-3939
Director, Office of Device Evaluation
Donna Bea Tillman (240) 276-3993
Director, Office of Compliance
Timothy Ulatowski (301) 276-0100
Director, Division of Bioresearch Monitoring
Michael Marcarelli (301) 276-0125
Director, Office of In Vitro Diagnostic Device Evaluation and Safety
Steven Gutman (240) 276-0375
Director, Office of Surveillance and Biometrics
Susan Gardner (240) 276-3351
Director
Janet Woodcock (301) 796-5400
Deputy Director
Douglas Throckmorton (301) 796-5400
Associate Director for Medical Informatics
Randy Levin (301) 827-7784
Associate Director for Planning and Business Informatics
Theresa Mullin (301) 796-5400
Associate Director for International Programs
Justina Molzon (301) 796-5400
Associate Director for Safety Policy and Communications
Paul Seligman (301) 796-5401
Associate Director for Regulatory Policy
Jane Axelrad (301) 796-5400
Director, Office of Executive Programs
Deborah Henderson (301) 796-3200
Director, Office of Management
Russell Abbott (301) 796-3300
Director, Office of Training and Communication
Nancy Smith (301) 796-3700
Director, Office of Information Technology
James Shugars (301) 827-6240
Director, Office of Counterterrorism and Emergency Coordination
Rosemary Roberts (301) 796-2210
Director
ShaAvhree Buckman (301) 796-2600
Director, Office of Clinical Pharmacology
Lawrence Lesko (301) 796-1656
Director, Office of Biostatistics
Robert O'Neill (301) 796-1700
Director
Deborah Autor (301) 796-3100
Deputy Director
Joe Famulare (301) 796-3100
Director, Division of Scientific Investigations
Leslie Ball (301) 796-3150
Deputy Director
Joseph Salewski (301) 796-3395
Chief, Good Clinical Practices Branch I
Constance Lewin (301) 796-3397
Chief, Good Clinical Practices Branch II
Tejashri Purohit-Sheth (301) 796-3402
Chief, GLP/Bioequivalence Branch
C.T. Viswanathan (301) 796-3394
Director
Robert Temple (301) 796-2270
Deputy Director
Rachel Behrman* (301) 796-2270
Director, Division of Drug Marketing, Advertising, and Communications
Thomas Abrams (301) 796-1200
Director
John Jenkins (301) 796-0700
Deputy Director
Sandra Kweder (301) 796-0700
Director, Office of Drug Evaluation I
Robert Temple* (301) 796-2270
Director, Office of Drug Evaluation II
Curtis Rosebraugh (301) 796-2310
Director, Office of Drug Evaluation III
Julie Beitz (301) 796-2100
Director, Office of Antimicrobial Products
Edward M. Cox (301) 796-1300
Director, Office of Oncology Products
Richard Pazdur (301) 796-2340
Director, Office of Nonprescription Products
Charles Ganley (301) 796-2060
Director
Helen Winkle (301) 796-2400
Deputy Director
Keith Webber (301) 796-2400
Director, Office of New Drug Quality Assessment
Moheb Nasr (301) 796-1900
Director, Office of Generic Drugs
Gary Buehler (240) 276-9310
Director, Office of Testing and Research
Vincent Vilker (301) 796-0200
Director, Office of Biotechnology Products
Steven Kozlowski (301) 796-2390
Director
Gerald Dal Pan (301) 796-2380
Deputy Director
Henry "Skip" Francis (301) 796-2380
Director, Division of Risk Management
Claudia Karwoski* (301) 796-9832
Director, Division of Epidemiology
Solomon Iyasu (301) 796-2370
Director, Division of Medication Error Prevention and Analysis
Carol Holquist (301) 796-2360
Director, Division of Pharmacovigilance I
Mark Avigan (301) 796-2350
Director, Division of Pharmacovigilance II
Ann McMahon* (301) 796-2350
Director
Jesse Goodman (301) 827-0372
Deputy Director
Karen Midthun (301) 827-0372
Associate Director for Research
Carolyn Wilson (301) 827-0377
Associate Director for Policy
Diane Maloney (301) 827-0372
Associate Director for Quality Assurance
Sheryl Lard-Whiteford (301) 827-0379
Associate Director for Review Management
Robert Yetter (301) 827-0373
Science Communications Advisor
Marc Kusinitz (301) 827-0372
Senior Advisor for International Affairs
Joan W. Blair (301) 827-0639
Senior Advisory for Counterterrorism/ Medical Countermeasures
Cynthia Kelley (301) 827-0636
Senior Advisor for Chemistry and Manufacturing Controls
Christopher Joneckis (301) 435-5681
Senior Regulatory Affairs Advisor
Lydia Falk (301) 827-9424
Director, Office of Biostatistics and Epidemiology
Robert Ball (301) 827-3034
Director, Office of Information Technology
Ginger Leo (301) 827-1368
Director, Office of Communication, Training, and Manufacturers Assistance
Lorrie McNeill (301) 827-2000
Director, Office of Management
James Sigg* (301) 827-1320
Director, Office of Blood Research and Review
Jay Epstein (301) 827-3518
Director, Office of Vaccines Research and Review
Norman Baylor (301) 827-0655
Director, Office of Cellular, Tissue, and Gene Therapies
Celia Witten (301) 827-6536
Director, Office of Compliance and Biologics Quality
Mary Anne Malarkey (301) 827-6190
Director, Division of Inspections and Surveillance
Gilliam Conley (301) 827-6220
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.